Analysis of immune status of the tumor microenvironment in esophageal cancer patients treated with PD-1 blockade therapy

Accompanying research No. 2 of "Analyses of immune status in malignant tumor patients": analysis of immune status of the tumor microenvironment in esophageal cancer patients treated with PD-1 blockade therapy - Analysis of immune status of the tumor microenvironment in esophageal cancer patients treated with PD-1 blockade therapy

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000043113

Enrollment

Registered

2021-01-25

Start date

2020-12-14

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Esophageal patients who joined in "Analyses of immune status in malignant tumor patients" and agreed with secondary use

Exclusion criteria

Exclusion criteria: Clinicians judge as ineligible cases.

Design outcomes

Primary

Measure	Time frame
Association between efficacy of PD-1 blockade therapy and immune profiling	—

Countries

Japan

Contacts

Public ContactYosuke Togashi

Chiba Cancer Center Research Institute

ytogashi@chiba-cc.jp0432645431

Outcome results